A 2018 trial led by @davidlevinemd found that home hospital patients
🚶 Moved around more
🛌 Slept better
🍽️ Ate better
😌 Felt more comfortable
Home hospital care helps healing. Learn more: https://t.co/QB8AmMZBnT
I’m excited to share the launch of the Eko CORE 500 - purpose-built to work with Eko’s AI algorithms for advanced disease screening. Congrats Eko Health! https://t.co/zvS1C1AmXd
We are pleased to share news of Cortica's $75M equity financing and the company's acquisitions of SpringTide and Melmed Center, and to welcome Optum Ventures, Deerfield Management, RA Capital Management, L.P. and Echo Health Ventur…https://t.co/nxXtg7TQli https://t.co/XbI2oUNAgq
Congratulations to Avive Solutions Inc. on their FDA PMA approval! The Avive Connect AED is a connected AED device that has an opportunity to change the game for victims of sudden cardiac arrest. At Questa we are pleased to be inve…https://t.co/bEt2xvCulQ https://t.co/Jb4p7oTsP2
Exciting opportunities to help build Barricaid - a great team and a disruptive RCT-validated technology that prevents future spine surgeries! https://t.co/Gb22SOisc0
Questa is proud to be an investor supporting Mark's vision for complex care delivered in the home - GO DISPATCH!
https://t.co/U8WgPC8MjF https://t.co/b8dWrlfau4
Great event happening this week for DMV-area life sciences/clinical trial executives - hosted by e-clinical software leader Medrio! https://t.co/7r5t5nPmKa
Questa Capital Management is pleased to invest in ACTO to support the fantastic team led by Parth Khanna, @kerramilli and Kapil Kalra - we are very excited about their vision for omnichannel learning, training and education for the…https://t.co/ocQSOFEgm7 https://t.co/QXZYZsFVma
Questa Capital Management is pleased to add to our investment in Calyxo, Inc. - Joe Catanese, Jee Shin and Doug Hughes and the team are building a very exciting company that will make a big positive impact on patients suffering from kidney stones! https://t.co/FyrvZJnXXg
Medrio continues to lead with innovative software to support quick-start-up and cost-effective clinical trials - de-centralized or traditional! https://t.co/IJ5HEXYx0W
Congratulations to Dr. Parker Babington MD, FAANS for completing 3 #Barricaid cases in the month of May. Thank you for helping to reduce your patients' reherniation rate by 81%!
For full benefit-risk information, please visit https://t.co/57cQdfY7T7